870 Followers on Owler

Toxys

is a provider of in vitro toxicity screening solutions to identify hazardous and potential carcinogenic properties for pharmaceutical sector... Read more
OverviewCompetitorsFundingNews & Insights

Toxys

is a provider of in vitro toxicity screening solutions to identify hazardous and potential carcinogenic properties for pharmaceutical sector... Read more
Toxys CEO: Giel Hendriks

CEO

Giel Hendriks

CEO Approval Rating

79/100

2014

Leiden
Other

Private

Pharmaceuticals & Biotechnology
BiotechnologyMedical Research & Laboratories
28368731 NAICS listing

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$2.3M

News

Partnership
Oct 08, 2025
Marketscreener
Charles River Laboratories International, Inc. and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing

Toxys Competitors

1Vivotecnia
2Vivaltes B.V.
3Gentronix
4Richmond Pharmacology
5SIMBEC-ORION
Unlock 2 + competitors

Trending Companies